Phase I/b Clinical Trial of 2cPA Completed in Taiwan (Osteoarthritis)

October 4, 2021

The Phase I/b clinical trial of 2-carba cyclic phosphatidic acid

(2ccPA; synthetic compound, drug candidate)

has been successfully completed in Taiwan.

This study targeted osteoarthritis, assessing safety and preliminary efficacy indicators.